Indometacine Zetpil Cf (Indometacin)

Indometacin works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This blocks the conversion of arachidonic acid into prostaglandins, which are mediators of inflammation, pain, and fever. Lower prostaglandin levels lead to reduced inflammatory responses and symptom relief.

The exact dose and frequency of Indometacine Zetpil Cf are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

The safety of indometacin in pregnancy and lactation has not been definitively established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indometacin is a potent non‑selective NSAID with strong anti‑inflammatory activity, often considered more effective for gout flares than many other NSAIDs. However, its gastrointestinal and renal risk profile can be higher, so clinicians weigh its benefits against potential adverse effects when choosing between indometacin and alternatives such as naproxen or ibuprofen.

Indometacine Zetpil Cf should be stored at room temperature, preferably below 25 °C. Keep the suppositories in their original packaging, protect them from moisture and direct heat, and ensure the container is tightly closed to maintain product integrity.

The product is a rectal suppository (zetpil) intended for insertion into the rectum. The prescriber will advise the appropriate number of suppositories per dose and the timing of administration, typically after bowel movements for optimal absorption.

Serious risks include gastrointestinal ulceration or bleeding, severe renal impairment, hepatotoxicity, and rare but life‑threatening hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should be monitored closely for signs of these events, especially during prolonged therapy.

Indometacine Zetpil Cf is contraindicated in patients with known hypersensitivity to indometacin or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in those who have experienced serious cardiovascular events related to NSAID use. It should also be avoided in late‑stage pregnancy.